Prostatic Hyperplasia: all 803 studies

Page 6 of 9. Open to participants first (174), then studies with results posted, then the rest; newest registration first within each.

• Urodynamics and Clinical Factors That Are Associated With Bladder Over-sensitivityStatus unknownNCT03486639
• Learning Curve of Digital Rectal Examination for Prostate Cancer Among InternshipStatus unknownNCT03479359
• Evaluation of the Satisfaction of the Patients Operated for a Mild Hyperplasie of the Prostate by Laser in Ambulatory SurgeryWithdrawnNCT03474419
• Prognostic Factor in the Patients With Benign Prostatic Hyperplasia Who Undergo Holmium Laser Enucleation of the ProstateCompletedNCT03460873
• Intraprostatic Injection of Botulinum Toxin A Versus Ethanol for Treatment of Patients With Benign Prostatic HyperplasiaCompletedNCT03385161Not applicable
• MRI Guided Transurethral HIFU for Various Prostate DiseasesCompletedNCT03350529Not applicable
• Clinical Outcomes of Laser ProstatectomyStatus unknownNCT03318991Not applicable
• High Power Thulium Vaporization vs Transurethral Resection of the Prostate for Treatment of BPHCompletedNCT03264482Not applicable
• Clinical Trial To Evaluate the Efficacy and Safety of CKD-397 in Benign Prostatic Hyperplasia PatientsCompletedNCT03246880Phase 3
• Pharmacokinetics and Safety/Tolerability of YY-201 in Comparison to Dutasteride and TadalafilCompletedNCT03240939Phase 1
• Taiwan ACE Beads for Embolization Therapy in Symptomatic Benign Prostatic HyperplasiaStatus unknownNCT03239652Not applicable
• ThuLEP vs. HoLEP vs. Monopolar Enucleation in Management of BPHCompletedNCT03230721Not applicable
• Benign Prostatic Hyperplasia (BPH) Mobile Application Pilot StudyCompletedNCT03228485
• French Aquablation Clinical Investigation Using Waterjet Ablation Therapy for Endoscopic Resection of Prostate TissueCompletedNCT03191734Not applicable
• Interest of a Systematic Assessment of the Treatment of LUTS in the Management of BPHCompletedNCT03179670
• Prostate Artery Embolization for the Treatment of Benign Prostatic HyperplasiaWithdrawnNCT03179228Not applicable
• Ejaculatory Sparing Transurethral Incision Of The Prostate (ES-TUIP) Versus Conventional TUIPStatus unknownNCT03176017Not applicable
• AQUABEAM India Study for the Treatment of Benign Prostatic HyperplasiaCompletedNCT03167294Not applicable
• Transurethral Plasmakinetic Enucleation of Prostate Versus Transurethral Resection of ProstateStatus unknownNCT03157726Not applicable
• The Effects of α-adrenergic Receptor Antagonists on Choroid and PupilCompletedNCT03144596Phase 4
• Acute Hemostasis Following the Use of the AQUABEAM® System for the Treatment of Benign Prostatic Hyperplasia IICompletedNCT03125889Not applicable
• Acute Hemostasis Following the Use of the AQUABEAM® System for the Treatment of Benign Prostatic HyperplasiaCompletedNCT03125863Not applicable
• Use of a Novel Radiopaque Embolic Agent in Prostatic Artery Embolisation for Symptomatic Benign Prostatic EnlargementStatus unknownNCT03109925Phase 2
• The Influence of Benign Prostatic Hyperplasia on Bladder FunctionStatus unknownNCT03098147
• Prostatic Hyperplasia Treatment and Cancer PreventionStatus unknownNCT03064282Early Phase 1
• Laser Enucleation of Prostate (LEP) Versus Transurethral Resection of Prostate (TURP)TerminatedNCT03062111Not applicable
• Innovative Minimally Invasive Options in Treatment of Urinary Problems Related to Prostate Enlargement (BPH) in MenWithdrawnNCT03043222Not applicable
• Clinical Results of Odyliresin (Iresine Celosia) in Symptomatic Benign Prostatic HyperplasiaCompletedNCT02977832Not applicable
• Clinical Trial to Compare the Solifenacin/Tamsulosin Combination Therapy With Tamsulosin Monotherapy for LUTS Due to BPHCompletedNCT02972268Phase 3
• Use of Autologous Adipose-Derived Stem/Stromal Cells (AD-cSVF) in Symptomatic Benign Prostate HypertrophyWithdrawnNCT02961114Phase 1/2
• Teleconsultation in Counter-reference Between Tertiary and Primary Care for Patients With Benign Prostatic HyperplasiaCompletedNCT02947958Not applicable
• Establishment and Clinical Assessment of a Prostate Cancer (PCa) Risk Model Based on the Updated Circulating Tumor Cell (CTC) Detection TechniqueStatus unknownNCT02940977
• Exploration of Ejaculation Changing Mechanism After Surgery for Benign Prostatic HyperplasiaTerminatedNCT02918227Not applicable
• Evaluation of the Potential Association Between 5α-reductase Inhibitors Prescription and Occurrence of High Grade Prostate CancersCompletedNCT02873117
• Prostatic Artery Embolization Versus Medical Treatment in Symptomatic Benign Prostatic HyperplasiaCompletedNCT02869971Phase 3
• Effectiveness and Safety of Adipose-derived Regenerative Cells for Reduction of Risk of Bladder Neck ContractureStatus unknownNCT02869061Phase 1/2
• The Efficacy and Safety of the Combination of Tamsulosin and Tadalafil in Men With Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia and Erectile DysfunctionStatus unknownNCT02862483Phase 3
• A Phase II Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Patients With BPHCompletedNCT02855892Phase 2
• Information Improvement for Surgical Patients Through Portable Video MediaCompletedNCT02846467Not applicable
• A Study to Investigate the Pharmacokinetic Drug Interactions Between Dutasteride and Tadalafil in Healthy Male SubjectsCompletedNCT02839122Phase 1
• Efficacy and Safety of Tamsulosin/Solifenacin Combination Therapy in Patients With Voiding Symptoms and Moderate to Severe Storage Symptoms Due to Benign Prostate HyperplasiaStatus unknownNCT02827578Phase 3
• Impact of Anticoagulants and Antiplatelets in Patients on Transurethral Resection of the ProstateWithdrawnNCT02822963
• Prostate Artery Embolization for Symptomatic Benign Prostatic HyperplasiaCompletedNCT02822924Not applicable
• The Zenflow Spring System Feasibility and Safety StudyStatus unknownNCT02786290Not applicable
• Sexual Steroids: Relationship Between Serum and Prostatic Tissue LevelCompletedNCT02778243Not applicable
• Ejaculatory Sparing vs. Non-ejaculatory Sparing GreenLight Laser Photoselective Vaporization of the ProstateStatus unknownNCT02749604Phase 4
• HoLEP (50W) vs. HoLEP (100W) for Treatment of BPHCompletedNCT02737241Not applicable
• PK and Safety of HCP1303 and Co-administration of HGP1201, HIP1402 Under Fed Condition in Healthy Male VolunteersCompletedNCT02715401Phase 1
• Study to Evaluate the Clinical Efficacy and Safety of Tamsulosin Alone or in Combination With Solifenacin for the Treatment in Men With Lower Urinary Tract Symptoms Including Overactive Bladder SymptomsCompletedNCT02715024Phase 4
• Pharmacokinetics and Safety of HCP1303 and Co-administration of HGP1201, HIP1402 in Healthy Male VolunteersCompletedNCT02712411Phase 1
• Prostate Embolization for Acute Urinary Retention StudyStatus unknownNCT02689830Not applicable
• Bipolar Versus Monopolar Resection of Benign Prostate HyperplasiaCompletedNCT02681471Not applicable
• Analysis of Prostatic Arterial Embolization for Benign Prostatic Hyperplasia Using Embosphere MicrospheresWithdrawnNCT02679430Not applicable
• Prostate Embolization for Massive Benign Prostatic Hypertrophy (BPH)TerminatedNCT02676544Phase 1/2
• A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HCP1303 CapsulesCompletedNCT02667938Phase 3
• Study to Compare the Safety and Pharmacokinetics of CKD-397CompletedNCT02645890Phase 1
• Clinical Study for the Evaluation of the Safety and Initial Performance of the ClearRing System for the Treatment of Benign Prostatic HyperplasiaCompletedNCT02639442Not applicable
• Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)CompletedNCT02637960Phase 2/3
• EC905 Pharmacokinetic Profile StudyCompletedNCT02634489Phase 1
• A Clinical Trial to Evaluate the Effects of Food on the Bioavailability of CKD-397 in Healthy Male SubjectsCompletedNCT02615782Phase 1
• Prostate Artery Embolization (PAE) for Treatment of Benign Prostatic HyperplasiaStatus unknownNCT02592473Not applicable
• Bioequivalence Study of Dutasteride Capsules in Healthy Japanese Male SubjectsCompletedNCT02578953Phase 1
• Prospective Controlled Randomized Study of PAE vs TURP for BPH Treatment.WithdrawnNCT02566551Not applicable
• Comparison of Different Energy Sources During TUR-PSuspendedNCT02533687Not applicable
• Effect of 50 and 100 IU Doses of Botox A Toxin Injection in BPH Patients.CompletedNCT02524236Early Phase 1
• Safety and Efficacy of OCL 503 in Prostate Artery EmbolizationCompletedNCT02509975Not applicable
• Bioavailability Study of Fixed Dose Combination (FDC) Dutasteride and Tamsulosin Hydrochloride (HCl) Relative to One Dutasteride and One Tamsulosin HCl Tablet in Healthy Male SubjectsCompletedNCT02509104Phase 1
• Aqueduct Irrigation System Clinical Protocol: Medical Device Investigational PlanStatus unknownNCT02496442Not applicable
• The PK Study of the JLP-1207 and Solifenacin/Tamsulosin in Healthy Male Volunteers.CompletedNCT02494349Phase 1
• Changes of the Hemodynamic Profiles on Bio Reactance Technique During TURP in Elderly PatientsCompletedNCT02483819
• Investigate the Effect of Food on the Pharmacokinetic of JLP-1207 in Healthy Male VolunteersCompletedNCT02447367Phase 1
• Saline With Alcohol in TransUrethral Resection aNd Photoselective Vaporisation of the ProstateCompletedNCT02429219Not applicable
• Human Prostate Tissue Model to Maintain and Study Prostate Cancer Stem CellsCompletedNCT02425800
• A Trial Assessing Peri-procedure Chemoprophylaxis During Transrectal Prostate Needle BiopsyCompletedNCT02423759Phase 4
• Feasibility Study of Photovaporisation of Prostate With a Limitated Length of Catheterization of 3 HoursCompletedNCT02401581Not applicable
• A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HGP0412 and HIP1402 in Patients With BPHCompletedNCT02390882Phase 3
• TRT on BPH Hypoganadal MetS Patients. Florence-PROTESTCompletedNCT02366975Phase 4
• Safety and Pharmacokinetic Characteristics of DKF-313CompletedNCT02352311Phase 1
• Does Benign Prostatic Obstruction Cause Hypertension?CompletedNCT02347436
• Ultrasound-Guided Photoselective Vaporization of the ProstateCompletedNCT02346500Early Phase 1
• HoLEP vs. Greenlight 532nm-laser PVEP vs. Bipolar TURP in Management of Moderate/ Large BPHCompletedNCT02332538Not applicable
• A Placebo Controlled Study of MR901 (Talaporfin Sodium Sodium + a Drug-activating Device) for the Relief of Lower Urinary Tract Symptoms Due to Benign Prostatic HyperplasiaCompletedNCT02326454Phase 2
• A Prospective Investigation Using the Expired Breath Ethanol TestCompletedNCT02304549
• Study to Investigate the Efficacy and Safety of GL2702 GLARS-NF1tablet and Harnal-D - Tablet in BPH Patients With LUTSCompletedNCT02303769Phase 3
• Trial of HoLEP vs. PVP in Treating BPH in Patients With Bleeding TendencyStatus unknownNCT02293759Phase 4
• GreenLight Laser Photoselective Vaporization of the Prostate vs Bipolar Transurethral Vaporization of the Prostate; RCTCompletedNCT02283684Phase 4
• Efficacy And Safety Of Combination Therapy For Treatment Of Overactive Bladder In Male Patients With Benign Prostatic Hyperplasia.Status unknownNCT02279615Phase 4
• Digital Rectal Exam Proficiency ToolStatus unknownNCT02278679
• Effect of 12 Weeks Treatment With Tadalafil vs Placebo on Lower Urinary Tract SymptomsCompletedNCT02252367Phase 4
• Study of the Effect of Testosterone Treatment on Metabolic Parameters and Urinary Symptoms in Bariatric PatientsCompletedNCT02248467
• Observational Study of Tamsulosin in Patients With Benign Prostatic HyperplasiaCompletedNCT02245555
• The Impact of Alna® Ocas® on Nocturia in Patients With Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH)CompletedNCT02245542
• Safety Profile of Secotex ® in Patients With Benign Prostatic HyperplasiaCompletedNCT02245529
• Observational Study of ALNA® (Tamsulosin) in Patients With Benign Prostatic Hyperplasia (BPH)CompletedNCT02245503
• Study to Characterise the Effect of Tamsulosin on Lower Urinary Tract Symptoms (LUTS) and Detrusor Motor Activity in Patients Affected by Benign Prostatic Hyperplasia (BPH) and Storage Urinary SymptomsCompletedNCT02245490Phase 4
• Prescription Event Monitoring in Patients With Benign Prostatic Hyperplasia (BPH)CompletedNCT02244346
• Efficacy, Tolerability and Safety of ALNA® in Patients With Benign Prostatic Syndrome (BPS)CompletedNCT02244333
• Observational Study in Patients With Functional Benign Prostatic Hyperplasia Symptoms Who Switched From Phytotherapy to ALNA® (Tamsulosin)CompletedNCT02244320
• Observational Study in Patients Suffering From Benign Prostatic Hyperplasia Treated With Alpha-adrenergic BlockadeCompletedNCT02244307
• FLOMAX® Versus Placebo, in Male Patients With Acute Urinary Retention Related to Benign Prostatic Hyperplasia (BPH)CompletedNCT02244294Phase 2

← Prostatic Hyperplasia overview